SpyGlass Pharma (Series D)

Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
June 04, 2025
Vertical
Ophthalmic Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
SpyGlass' Drug Delivery Platform aims to provide multiple years of medical therapy, addressing the need for long-term management of glaucoma and other chronic ophthalmic diseases.
Market
Glaucoma and other chronic ophthalmic diseases
Location
Aliso Viejo, California, United States

Links